Ohr Pharmaceutical Director Thomas Riedhammer receives $190K in 2013

Ohr Pharmaceutical reports 2013 executive compensation

By ExecPay News

Published: March 7, 2014

Ohr Pharmaceutical reported fiscal year 2013 executive compensation information on March 7, 2014.
In 2013, six executives at Ohr Pharmaceutical received on average a compensation package of $130K, a 50% decrease compared to previous year.
Average pay of disclosed executives at Ohr Pharmaceutical
Thomas Riedhammer, Director, received $190K in total. 100% of Riedhammer's compensation, or $190K, was in option awards.
June Almenoff, Director, received a compensation package of $180K. 100% of the compensation package, or $180K, was in option awards.
Irach Taraporewala, Chief Executive Officer, earned $163K in 2013, a 72% decrease compared to previous year.
Sam Backenroth, Chief Financial Officer, received $131K in 2013, which decreases by 61% compared to 2012.
Ira Greenstein, Chairman, earned $58K in 2013, a 8% decrease compared to previous year.
Orin Hirschman, Director, received $58K in 2013, which decreases by 8% compared to 2012.

Related executives

Ira Greenstein

Ohr Pharmaceutical

Chairman

Orin Hirschman

Ohr Pharmaceutical

Director

Thomas Riedhammer

Ohr Pharmaceutical

Director

June Almenoff

Ohr Pharmaceutical

Director

Irach Taraporewala

Ohr Pharmaceutical

Chief Executive Officer

Sam Backenroth

Ohr Pharmaceutical

Chief Financial Officer

You may also like

Source: SEC filing on March 7, 2014.